Hospital trial aims to speed up depression relief with ketamine
NCT ID NCT06508710
Summary
This study is testing if adding the drug ketamine to a standard antidepressant (venlafaxine) helps hospitalized patients with severe depression feel better more quickly. It will involve 60 adults with major depression to see if the combination reduces symptoms faster, lowers suicidal thoughts, and shortens hospital stays. The main goal is to see if patients improve significantly within one week of starting treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE EPISODE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bicetre Hospital - CRC
NOT_YET_RECRUITINGLe Kremlin-Bicêtre, 94250, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CEA/SHFJ
ACTIVE_NOT_RECRUITINGOrsay, 94401, France
-
EPS Barthélémy Durand
NOT_YET_RECRUITINGÉtampes, 91152, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Psychiatry unit
RECRUITINGLe Kremlin-Bicêtre, France, 94270, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.